Cost-effectiveness analysis of atezolizumab plus chemotherapy in the first-line treatment of extensive-stage small-cell lung cancerKexun Zhou, Qiu Li, Jiaxing Huang et al.|Lung Cancer|2019Cited by 75
S-1 plus Raltitrexed for Refractory Metastatic Colorectal Cancer: A Phase II TrialYe Chen, Jiyan Liu, Meng Qiu et al.|The Oncologist|2019Cited by 18